With a vital obesity launch now underway in the U.S., Novo Nordisk is casting its attention eastward as it shores up the prospects of its Wegovy pill in Europe and beyond.  | Novo will invest 432 ...

Esperion has acquired Corstasis Therapeutics and its nasal spray Enbumyst, which was approved by the FDA six months ago. Esperion paid $75 million upfront and earmarked $180 million for potential ...

Following an extensive Middle East military build-up by the U.S. in recent weeks, the U.S. and Israel on Feb. 28 launched attacks across Iran. In response, Iran launched retaliatory attacks on Israel, ...

As it ramps up its rollout of the first twice-yearly HIV pre-exposure prophylaxis (PrEP) medicine, Gilead Sciences is tapping into a beloved early-aughts track to familiarize consumers with Yeztugo.